Second malignant neoplasia in patients with T1 glottic cancer treated with radiation

Laryngoscope

Volumn 108, Issue 12, 1998, Pages 1853-1855

  Fujita, Mihoko ^a   Rudoltz, Marc S ^b   Canady, Daniel J ^c   Patel, Pushpa ^a   Machtay, Mitchel ^c   Pittard, Melissa Q ^a   Mohiuddin, Mohammed ^a   Regine, William F ^a  

^a UNIVERSITY OF KENTUCKY   (United States)

^b St Vincent's Medical Center Jacksonville   (United States)

^c UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

Glothic cancer; Radiotherapy; Second malignant tumors

Indexed keywords

ARTICLE; CANCER RADIOTHERAPY; CONTROLLED STUDY; DIGESTIVE SYSTEM CANCER; GLOTTIS; HUMAN; LARYNX CARCINOMA; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; RESPIRATORY TRACT CANCER; RETROSPECTIVE STUDY; SECOND CANCER; SQUAMOUS CELL CARCINOMA; SURVIVAL RATE;

EID: 0031742803     PISSN: 0023852X     EISSN: None     Source Type: Journal    
DOI: 10.1097/00005537-199812000-00016     Document Type: Article

References (16)

1. Harwood AR, Hawkins HV, Rider, WD, et al. Radiotherapy of early glottic cancer. Int J Radiat Oncol Biol Phys 1979; 5:473-6.
2. Wagenfeld DJH, Harwood AR, Bryce DP, et al. Second primary respiratory tract malignancies in glottic carcinoma. Cancer 1980;46:1883-6.
3. McDonald S, Haie C, Rubin P, et al. Second malignant tumors in patients with laryngeal carcinoma: Diagnosis, treatment, and prevention. Int J Radiat Oncol Biol Phys 1989;17:457-65.
4. Warren S, Gates O. Multiple primary malignant tumors: a survey of literature and statistical study. Am J Cancer 1932;16:1358-1414.
5. Mathews DE, Farewell V. Using and Understanding Medical Statistics. Basel: S. Kaager; 1985:65-78.
6. Hill ID. Computing man years at risk. Br J Prev Soc Med 1972;26:232-4.
7. Berry GD. The analysis of mortality by the subject-years method. Biometrics 1983;39:173-84.
8. Rubin P, Zagars G, Chiang C, et al. Hodgkin's disease: is there a price for successful treatment. A 25 year experience. [Appendix: Statistical Methodology]. Int J Radiat Oncol Biol Phys 1986;12:153-66.
9. Incidence and Mortality Data: 1973-77. NCI Monograph, 57, 1981.
10. Hill ID. Computing man-years at risk. Br J Prev Soc Med 1974;26:132-4.
11. Slaughter DP, Southwick H, Smejkal W. "Filed cancerization" in oral stratified squamous epithelium: clinical implication of multicentric origin. J Am Cancer Soc 1953;6:968-78.
12. De Viers N, Oldekalter P, Snow GB. Multiple primary tumors in patients with laryngeal squamous cell hyperplasia. Arch Otorhinolaryngol 1986;143(2):143-5.
13. Wynder EL, Mushinski MM, Soivak JC. Tobacco and alcohol consumption in relation to the development of multiple primary cancers. Cancer 1977;40(4):1872-8.
14. Silvermanno G, Gorsky M, Greenspan D. Tobacco usage in patients with head and neck carcinomas: a follow-up study on habit changes and second primary oral-oropharyngeal cancers. J Am Dent Assoc 1983;106(1):33-5.
15. Lippman SM, Kessler JK, Meyskens FL. Retinoids as preventive and therapeutic anticancer agents (part 1). Cancer Treat Rep 1987;71(4):391-405.
16. Lippman SM, Kessler JK, Meyskens FL. Retinoids as preventive and therapeutic anticancer agents (part 2). Cancer Treat Rep 1987;71(5):493-515.